{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A survey to understand usage pattern of Pregabalin + Duloxetine in the treatment of neuropathic pain in India

Survey Questionnaire Form
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients of Neuropathic pain do you see in a month? *

  2. From your clinical experience, mention the most common type of Neuropathies that present to you for diagnosis? *

  3. Do you consider pregabalin as a first-line treatment for neuropathy? *

  4. What percentage of your neuropathy patients achieve satisfactory symptom relief with pregabalin alone? *

  5. In your practice, what proportion of neuropathy patients require combination therapy involving pregabalin? *

  6. What percentage of your neuropathy patients are currently prescribed FDC of pregabalin + duloxetine treatment? *

  7. In your experience, how effective do you find FDC of pregabalin + duloxetine in managing neuropathy symptoms? *
  8. On a scale of 1 to 5, How satisfied are you with the current dosing options available for FDC of pregabalin + duloxetine? (5 being very satisfied) *

  9. In your experience, how quickly do patients respond to FDC of pregabalin + duloxetine treatment? *

  10. What are different patient profiles while choosing pregabalin+duloxetine in neuropathic pain? *
  11. How often do you adjust the dosage of FDC of pregabalin + duloxetine for optimal symptom management? *

  12. On average, how long do your patients remain on FDC of pregabalin + duloxetine treatment? *

  13. Do you prefer prescribing the fixed dose combination over giving pregabalin + duloxetine separately? If no, please specify reason. *

  14. In your experience, does FDC of pregabalin + duloxetine provide long-term benefits for peripheral neuropathy patients? *

  15. Have you observed any differences in treatment response with pregabalin + duloxetine over plain pregabalin in diabetic neuropathy patients? *

  16. Have you observed any differences in treatment response based on patient’s gender when prescribing FDC of pregabalin + duloxetine in peripheral neuropathy patients? *

  17. What percentage of your patients report satisfactory compliance with FDC of pregabalin + duloxetine treatment? *

  18. How do you typically monitor the effectiveness of FDC of pregabalin + duloxetine treatment in your patients? *

  19. How satisfied are your patients with the response of the FDC of pregabalin and duloxetine in managing their peripheral neuropathic pain? (5 being very satisfied) *

  20. How satisfied are your patients with the tolerability of the FDC of pregabalin and duloxetine in managing their peripheral neuropathic pain? (5 being very satisfied) *

  21. In your experience, what are the different types of neuropathic pain where FDC of pregabalin + duloxetine is more effective and why? *
  22. Do you find FDC of pregabalin + duloxetine more effective than other medications commonly prescribed for neuropathy? *

  23. What percentage of adults exhibit satisfactory tolerance FDC of pregabalin + duloxetine? *

  24. How do you assess the long-term efficacy of the FDC of pregabalin + duloxetine in managing neuropathic pain? *
  25. What proportion of your neuropathy patients require dose titration with FDC of pregabalin + duloxetine? *

  26. What percentage of your neuropathy patients experience significant improvement in sleep quality with FDC of pregabalin + duloxetine? *

  27. How frequently do you encounter patients who discontinue FDC of pregabalin + duloxetine due to lack of efficacy? *

  28. In your experience, do patients with neuropathic pain having comorbidities influence your decision to prescribe FDC of pregabalin + duloxetine and Why? *
  29. Based on your experience, do you think additional research is needed to better understand FDC of pregabalin + duloxetine in neuropathy management? *

  30. In your opinion, what advantage does FDC of pregabalin + duloxetine offer over other combinations in neuropathy management? *
  31. How would you rate your overall experience with prescribing FDC of pregabalin + duloxetine in neuropathy management? (5 being very satisfied) *

  32. How generally in your treatment protocol in managing Neuropathy ,do you add frequently Benfothiamine in your pain prescription *